Metropolitan Life Insurance Company (MetLife)’s Lemonade LMND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,817
Closed -$46.2K 1184
2024
Q1
$46.2K Hold
2,817
﹤0.01% 1442
2023
Q4
$45.4K Hold
2,817
﹤0.01% 1500
2023
Q3
$32.7K Hold
2,817
﹤0.01% 1631
2023
Q2
$47.5K Hold
2,817
﹤0.01% 1454
2023
Q1
$40.2K Hold
2,817
﹤0.01% 1521
2022
Q4
$38.5K Hold
2,817
﹤0.01% 1629
2022
Q3
$59.7K Buy
2,817
+372
+15% +$8.46K ﹤0.01% 1337
2022
Q2
$44.6K Buy
+2,445
New +$51.5K ﹤0.01% 1576
2022
Q1
Sell
-946
Closed -$39.8K 2493
2021
Q4
$39.8K Hold
946
﹤0.01% 2721
2021
Q3
$63.4K Sell
946
-37
-4% -$2.98K ﹤0.01% 2732
2021
Q2
$108K Buy
983
+309
+46% +$28.1K ﹤0.01% 2561
2021
Q1
$62.8K Buy
674
+427
+173% +$55.2K ﹤0.01% 2516
2020
Q4
$30.3K Sell
247
-8
-3% -$590 ﹤0.01% 2501
2020
Q3
$12.7K Buy
+255
New +$16K ﹤0.01% 2544

Other funds holding LMND

Metropolitan Life Insurance Company (MetLife)'s LMND Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Lemonade (LMND) in Q2 2024, closing a stake of 2,817 shares — an estimated $46.2K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in LMND in Q3 2020 and held it in 14 quarters. The position peaked at $108K in Q2 2021. 214 funds tracked by Wall St. Rank hold LMND as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Lemonade position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,817 Lemonade shares in Q2 2024, an estimated $46.2K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Lemonade in Q3 2020 and held it in 14 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Lemonade position peaked at $108K in Q2 2021.
  • 214 funds tracked by Wall St. Rank held Lemonade as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.